Staar Surgical (STAA) EBIAT (2016 - 2026)
Staar Surgical (STAA) has disclosed EBIAT for 17 consecutive years, with -$21.8 million as the latest value for Q1 2026.
- For the quarter ending Q1 2026, EBIAT rose 36.41% year-over-year to -$21.8 million, compared with a TTM value of -$95.2 million through Jan 2026, down 371.11%, and an annual FY2026 reading of -$88.2 million, down 336.56% over the prior year.
- EBIAT was -$21.8 million for Q1 2026 at Staar Surgical, down from $9.4 million in the prior quarter.
- Across five years, EBIAT topped out at $13.0 million in Q3 2022 and bottomed at -$54.2 million in Q1 2025.
- Average EBIAT over 5 years is -$3.8 million, with a median of $5.4 million recorded in 2023.
- The sharpest move saw EBIAT surged 669.44% in 2023, then crashed 1523.57% in 2025.
- Year by year, EBIAT stood at $1.0 million in 2022, then soared by 669.44% to $7.8 million in 2023, then tumbled by 541.31% to -$34.2 million in 2024, then soared by 127.39% to $9.4 million in 2025, then plummeted by 332.2% to -$21.8 million in 2026.
- Business Quant data shows EBIAT for STAA at -$21.8 million in Q1 2026, $9.4 million in Q3 2025, and -$28.6 million in Q2 2025.